Flags of India and Israel (Photos: Pexels)
India’s Sun Pharma and Israel’s Moebius Medical published new data on MM-II, a non-opioid treatment for knee osteoarthritis. The studies, featured in the peer-reviewed Osteoarthritis and Cartilage journal, show that a single injection of MM-II can provide long-lasting pain relief and protect cartilage.
The drug, developed in Israel and supported by Sun Pharma, recently received Fast Track Designation from the US FDA. New findings will be presented at the OARSI 2025 World Congress.
In a major escalation along India's western front, the Pakistani army carried out multiple airspace…
New Zealand Prime Minister Christopher Luxon has highlighted India's importance to Wellington's prosperity, security, and…
Bangladesh's interim government, headed by Nobel Laureate Muhammad Yunus, is seriously considering banning Sheikh Hasina's…
The Board of Control for Cricket in India (BCCI) has decided to suspend the remainder…
External Affairs Minister S Jaishankar held a telephonic conversation with UK Foreign Secretary David Lammy…
World Bank has no role beyond being the facilitator of the Indus WatersTreaty between India…
